Influenza [NEW TOPIC PAGE]

Main|Search|PHGKB

From CDC-Authored Genomics Publication Database

This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.

---

• Structural and Molecular Characterization of the Hemagglutinin from the Fifth Epidemic Wave A(H7N9) Influenza Viruses.  
  Yang Hua et al. Journal of virology 2018 May
• Pathogenesis and transmission of genetically diverse swine-origin H3N2v influenza A viruses from multiple lineages isolated in the United States, 2011-2016.  
  Sun Xiangjie et al. Journal of virology 2018 May
• Influenza-Associated Acute Necrotizing Encephalopathy in Siblings.  
  Howard Ashley et al. Journal of the Pediatric Infectious Diseases Society 2018 May
• Mapping of the US Domestic Influenza Virologic Surveillance Landscape.  
  Jester Barbara et al. Emerging infectious diseases 2018 Jul (7)
• Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United States.  
  Rolfes Melissa A et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Mar
• Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.  
  Matos Aline R et al. Antiviral research 2018 Mar
• Molecular Analysis of Influenza A(H3N2) and A(H1N1)pdm09 Viruses circulating in the Democratic Republic of Congo, 2014.  
  Nkwembe Edith et al. Journal of harmonized research in medical and health sciences 2016 Dec 3(4) 247-264
• Antigenically diverse swine-origin H1N1 variant influenza viruses exhibit differential ferret pathogenesis and transmission phenotypes.  
  Pulit-Penaloza Joanna A et al. Journal of virology 2018 Mar
• Identification and characterization of influenza A viruses in selected domestic animals in Kenya, 2010-2012.  
  Munyua Peninah et al. PloS one 2018 13(2) e0192721
• Evolution and Virulence of Influenza A Virus Protein PB1-F2.  
  Kamal Ram P et al. International journal of molecular sciences 2017 Dec (1)
• An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.  
  DeZure Adam D et al. NPJ vaccines 2017 215
• Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.  
  Carter Tonia C et al. Journal of medical virology 2017 Oct
• Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.  
  Hassan Ahmed O et al. PloS one 2017 (10) e0186244
• Multiplex RT-PCR for Simultaneous Surveillance of Influenza A and B Viruses.  
  Zhou Bin et al. Journal of clinical microbiology 2017 Oct
• Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.  
  Gubareva Larisa V et al. The Journal of infectious diseases 2017 Sep (suppl_4) S566-S574
• Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.  
  Pulit-Penaloza Joanna A et al. The Journal of infectious diseases 2017 Sep (suppl_4) S499-S507
• Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets. 
  Smith Gale E et al. Virology 2017 Jun 50990-97
• Measuring influenza laboratory capacity: use of a tool to measure improvements.  
  Kennedy Pam et al. BMC infectious diseases 2017 Jun 17(1) 431
• Novel influenza A viruses and pandemic threats.  
  Uyeki Timothy M et al. Lancet (London, England) 2017 Jun (10085) 2172-2174
• Molecular epidemiology of influenza A(H1N1)PDM09 hemagglutinin gene circulating in São Paulo State , Brazil: 2016 anticipated influenza season.  
  Santos Katia Corrêa de Oliveira et al. Revista do Instituto de Medicina Tropical de Sao Paulo 2017 Apr 59e9
• Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017.  
  Iuliano A Danielle et al. MMWR. Morbidity and mortality weekly report 2017 Mar (9) 254-255
• Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.  
  Rekstin Andrey et al. BioMed research international 2017 20179359276
• Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.  
  Alan Hampson et al. Vaccine 2017 Jan
• Influenza virus exploits tunneling nanotubes for cell-to-cell spread.  
  Kumar Amrita et al. Scientific reports 2017 Jan 740360
• Shifting clade distribution, reassortment, and emergence of new subtypes of highly pathogenic avian influenza A(H5) viruses collected in Vietnamese poultry from 2012 to 2015.  
  Nguyen Diep T et al. Journal of virology 2016 Dec
• Viral factors in influenza pandemic risk assessment.  
  Lipsitch Marc et al. eLife 2016 Nov
• Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.  
  Isakova-Sivak Irina et al. Virology 2016 Nov 500209-217
• A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.  
  Mishin Vasiliy P et al. Journal of clinical microbiology 2016 Oct
• Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia.  
  Zhang Yange et al. Journal of clinical microbiology 2016 Oct
• Inhibition of influenza A virus matrix and nonstructural gene expression using RNA interference.  
  McMillen Cynthia M et al. Virology 2016 Jul 497171-184
• Reversion of Cold-adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.  
  Zhou Bin et al. Journal of virology 2016 Jul
• Multiplex assay for subtyping avian influenza A viruses by cDNA hybridization and adapter-mediated amplification.  
  Yang Genyan et al. Applied microbiology and biotechnology 2016 Jul
• Sentinel Surveillance for Influenza among Severe Acute Respiratory Infection and Acute Febrile Illness Inpatients at Three Hospitals in Ghana.  
  Jones Alexander H et al. Influenza and other respiratory viruses 2016 May
• Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015.  
  Flannery Brendan et al. The Journal of infectious diseases 2016 May
• The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses. 
  Yang Hua et al. Journal of virology 2016 Apr
• A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.  
  Liu Feng et al. Virology 2016 Mar 492197-203
• Mammalian pathogenesis and transmission of H7N9 influenza viruses from three waves, 2013-2015.  
  Belser Jessica A et al. Journal of virology 2016 Feb
• Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins.  
  Batra Jyoti et al. Scientific reports 2016 619063
• Natural co-infection of influenza A/H3N2 and A/H1N1pdm09 viruses resulting in a reassortant A/H3N2 virus.  
  Rith Sareth et al. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015 Nov 108-111
• Surveillance for Severe Acute Respiratory Infections (SARI) in Southern Arizona, 2010-2014.  
  Wansaula Zimy et al. Influenza and other respiratory viruses 2015 Nov
• Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.  
  Shcherbik Svetlana et al. Journal of virological methods 2015 Oct
• Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-2013.  
  Su Su et al. Influenza and other respiratory viruses 2016 Mar (2) 86-90
• Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.  
  Shcherbik Svetlana et al. PloS one 10(9) e0138951
• Factors associated with real time RT-PCR cycle threshold values among medically attended influenza episodes.  
  Spencer Sarah et al. J. Med. Virol. 2015 Sep 3.
• Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.  
  Wilson Jason R et al. Virology 2015 Aug 25. 485252-262
• Live animal markets in Minnesota: a potential source for emergence of novel influenza A viruses and interspecies transmission.  
  Choi Mary J et al. Clin. Infect. Dis. 2015 Jul 29.
• Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites.  
  An Yanming et al. J. Proteome Res. 2015 Sep 4. (9) 3957-69
• Transmission of H7N9 influenza viruses with polymorphism at PB2 residue 627 in chickens and ferrets.  
  Luk Geraldine S M et al. J. Virol. 2015 Jul 22.
• Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.  
  Ampofo William K et al. Vaccine 2015 Jul 3.
• Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs. 
  Johnson Adam et al. PLoS ONE 2015 10(6) e0128982
• Global circulation patterns of seasonal influenza viruses vary with antigenic drift.  
  Bedford Trevor et al. Nature 2015 Jul (7559) 217-20
• Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.  
  Stucker K M et al. Euro Surveill. 2015 20(18)
• Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014.  
  Donis Ruben O et al. Influenza Other Respir Viruses 2015 May 12.
• Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older Adults.  
  Najarro Kevin et al. J. Infect. Dis. 2015 Mar 31.
• Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.  
  Kamal Ram P et al. J. Virol. 2015 Jun 89(11) 5835-46
• Application of a Seven-Target Pyrosequencing Assay To Improve the Detection of Neuraminidase Inhibitor-Resistant Influenza A(H3N2) Viruses.  
  Tamura Daisuke et al. Antimicrob. Agents Chemother. 2015 Apr (4) 2374-9
• Structural and functional analysis of surface proteins from an A(H3N8) influenza virus isolated from New England harbor seals. 
  Yang Hua et al. J. Virol. 2015 Mar 89(5) 2801-12
• Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.  
  Okomo-Adhiambo Margaret et al. Emerging Infect. Dis. 2015 Jan 21(1) 136-41
• Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness.  
  Davis C Todd et al. MBio 2014 5(6)
• NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infection.  
  Ranjan Priya et al. Eur. J. Immunol. 2015 Mar 45(3) 758-72
• The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease.  
  Peng Xinxia et al. Nat. Biotechnol. 2014 Dec 32(12) 1250-5
• Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.  
  Alymova Irina V et al. PLoS ONE 2014 9(11) e111603
• Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011.  
  Horm Srey Viseth et al. PLoS ONE 2014 (10) e110713
• Improving pandemic influenza risk assessment.  
  Russell Colin A et al. Elife 2014 3e03883
• Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.  
  Kulkarni Raveendra R et al. J. Virol. 2014 Dec 88(24) 13990-4001
• Identification of molecular markers associated with alteration of receptor-binding specificity in a novel genotype of highly pathogenic avian influenza A(H5N1) viruses detected in Cambodia in 2013.  
  Rith Sareth et al. J. Virol. 2014 Dec 88(23) 13897-909
• Molecular determinants of influenza virus pathogenesis in mice.  
  Kamal Ram P et al. Curr. Top. Microbiol. Immunol. 2014 385243-74
• Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.  
  Wilson Jason R et al. Virology 2014 Jun 458-459114-24
• Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013.  
  Pabbaraju Kanti et al. Emerging Infect. Dis. 2014 May 20(5) 887-91
• Genetic characterization of clade 2.3.2.1 avian influenza A(H5N1) viruses, Indonesia, 2012.  
  Dharmayanti Ni Luh Putu Indi et al. Emerging Infect. Dis. 2014 Apr 20(4) 671-4
• Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines.  
  Shcherbik Svetlana V et al. PLoS ONE 2014 9(3) e92580
• Multiple reassortment events among highly pathogenic avian influenza A(H5N1) viruses detected in Bangladesh.  
  Gerloff Nancy A et al. Virology 2014 Feb 450-451297-307
• LABEL: fast and accurate lineage assignment with assessment of H5N1 and H9N2 influenza A hemagglutinins.  
  Shepard Samuel S et al. PloS one 2014 (1) e86921
• Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.  
  Shcherbik Svetlana et al. J. Virol. Methods 2014 Jan 19518-25
• Localization of pandemic 2009 H1N1 influenza A virus RNA in lung and lymph nodes of fatal influenza cases by in situ hybridization: new insights on virus replication and pathogenesis.  
  Bhatnagar Julu et al. J. Clin. Virol. 2013 Mar 56(3) 232-7
• The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001-2009.  
  Vuong Cuong D et al. Influenza Other Respir Viruses 2013 Nov 7(6) 1151-7
• Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.  
  Ledgerwood J E et al. Clin. Vaccine Immunol. 2012 Nov 19(11) 1792-7
• WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.  
  Klimov Alexander I et al. Vaccine 2012 Oct 5. 30(45) 6461-71
• Molecular epidemiology of influenza A(H1N1)pdm09 viruses from Pakistan in 2009-2010.  
  Bashir Aamir Uzma et al. PLoS ONE 2012 7(8) e41866
• Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010.  
  Nguyen Tung et al. Virology 2012 Oct 25. 432(2) 405-16
• Evolutionary history and phylodynamics of influenza A and B neuraminidase (NA) genes inferred from large-scale sequence analyses.  
  Xu Jianpeng et al. PLoS ONE 2012 7(7) e38665
• Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.  
  Kim Yeu-Chun et al. Eur J Pharm Biopharm 2012 Jun 81(2) 239-47
• Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011.  
  Kitikoon Pravina et al. J. Virol. 2012 Jun 86(12) 6804-14
• The 3' untranslated regions of influenza genomic sequences are 5'PPP-independent ligands for RIG-I.  
  Davis William G et al. PLoS ONE 2012 7(3) e32661
• A distinct lineage of influenza A virus from bats.  
  Tong Suxiang et al. Proc. Natl. Acad. Sci. U.S.A. 2012 Mar 13. 109(11) 4269-74
• Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.  
  Nguyen Ha T et al. Antiviral Res. 2012 Mar 93(3) 381-6
• Genetic diversity of HA1 domain of hemagglutinin gene of pandemic influenza H1N1pdm09 viruses in New Delhi, India.  
  Mir Muneer A et al. J. Med. Virol. 2012 Mar 84(3) 386-93
• Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection. 
  DeVries Aaron et al. Influenza Other Respir Viruses 2012 Nov 6(6) e85-8
• Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR.  
  Van Tam T et al. J. Clin. Microbiol. 2012 Mar 50(3) 891-6
• Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.  
  Cilloniz Cristian et al. J. Virol. 2012 Mar 86(5) 2437-46
• Semi-quantitative analysis of influenza samples using the Luminex xTAG(®) respiratory viral panel kit.  
  Smith Jerome et al. Toxicol. Mech. Methods 2012 Apr 22(3) 211-7
• Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11.  
  Sleeman Katrina et al. Emerging Infect. Dis. 2011 Nov 17(11) 2043-6
• Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010.  
  Shu Bo et al. Virology 2012 Jan 5. 422(1) 151-60
• Differential microRNA expression and virulence of avian, 1918 reassortant, and reconstructed 1918 influenza A viruses.  
  Li Yu et al. Virology 2011 Dec 20. 421(2) 105-13
• DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.  
  Ledgerwood Julie E et al. Lancet Infect Dis 2011 Dec 11(12) 916-24
• Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus.  
  Belser Jessica A et al. PLoS ONE 2011 6(9) e25091
• Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation.  
  Sharma Kulbhushan et al. PLoS ONE 2011 6(6) e20215
• Pandemic (H1N1) 2009 virus revisited: an evolutionary retrospective.  
  Christman Mary C et al. Infect. Genet. Evol. 2011 Jul 11(5) 803-11

Go to CDC-Authored Genomics Publication Database